Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses – IVY Network, September 1, 2022-March 30, 2023

By sjmartinez • November 14, 2024

Lewis NM, Harker EJ, Leis A, Zhu Y, Talbot HK, Grijalva CG, Halasa N, Chappell JD, Johnson CA, Rice TW, Casey JD, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, DeCuir J, Surie D, Dawood FS, Ellington S, Self WH, Martin ET. Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023. Vaccine. 2024 Nov 7;43(Pt 2):126492. doi: 10.1016/j.vaccine.2024.126492. Epub ahead of print. PMID: 39515195.

Tags: bias, covid-19, Estimation, Influenza, Publications, Pulmonary, Critical Care & Sleep Medicine, RSV, vaccine effectiveness

The Ethics of Gene Therapy for Sickle Cell Disease

Patel A, Kuo A. The Ethics of Gene Therapy for Sickle Cell Disease. Cureus. 2025 Mar 23;17(3):e81037. doi: 10.7759/cureus.81037. PMID: 40264617; PMCID: PMC12013961.

Surviving the Odds: Primary Cardiac Lymphoma With Locoregional Lymph Node Involvement Complicated by Pericardial Effusion and Arrhythmia

Bachour K, Shah S, Reichl A, Chia J, Shabsovich DS, Castillo A, Cho G. Surviving the Odds: Primary Cardiac Lymphoma With Locoregional Lymph Node Involvement[...]

Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and Syphilis in Pregnancy: the Quest to Eliminate Maternal and Vertical Transmission

Joseph Davey D, de Voux A, Shaetonhodi N, Marks M, Frigati L, Kufa T. Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and[...]